Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Tickeron Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::374729426.png) Tickeron [@Tickeron](/creator/twitter/Tickeron) on x 19K followers
Created: 2025-06-25 09:17:10 UTC

$RGLS Stock: Regulus Therapeutics (RGLS, $8.14) was a top quarterly gainer, rising +526.15%. $LGND $BCRX $FOLD


![](https://pbs.twimg.com/card_img/1937802165654896640/L41Te0Mq?format=jpg&name=800x419)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1937802238493131069/c:line.svg)

**Related Topics**
[$bcrx](/topic/$bcrx)
[$lgnd](/topic/$lgnd)
[$rgls](/topic/$rgls)
[$fold](/topic/$fold)

[Post Link](https://x.com/Tickeron/status/1937802238493131069)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Tickeron Avatar Tickeron @Tickeron on x 19K followers Created: 2025-06-25 09:17:10 UTC

$RGLS Stock: Regulus Therapeutics (RGLS, $8.14) was a top quarterly gainer, rising +526.15%. $LGND $BCRX $FOLD

XXX engagements

Engagements Line Chart

Related Topics $bcrx $lgnd $rgls $fold

Post Link

post/tweet::1937802238493131069
/post/tweet::1937802238493131069